Overview
Bruce Redman is an Oncologist practicing medicine in Ann Arbor, Michigan.
Dr. Redman is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, and Familial Wilms Tumor 2.
He is actively involved in clinical research, co-authoring 30 peer reviewed articles and participating in 1 clinical trial.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- INDEMNITY
- POS
- PPO
Locations
1500 E Medical Center Dr, Ann Arbor, MI 48109
3621 S State St, Ann Arbor, MI 48108
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Rogel Cancer Center
Rashmi Chugh is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Chugh is highly rated in 32 conditions, according to our data. Her clinical expertise encompasses Adult Soft Tissue Sarcoma, Epithelioid Sarcoma, Desmoid Tumor, and Ewing Sarcoma.
Rogel Cancer Center
Dr. Francis Worden received his medical degree from the Indiana University School of Medicine in 1993. Prior to attending medical school, he worked as a registered pharmacist at a large community hospital in Indianapolis. In 1997, Dr. Worden completed a combined residency in internal medicine and pediatrics at the Detroit Medical Center and finished a medical oncology/hematology fellowship at the University of Michigan. In July 2000, Dr. Worden joined the faculty at the University of Michigan Rogel Cancer Center, where he is currently working as a clinical investigator with both the multidisciplinary head and neck oncology team and the multidisciplinary lung cancer team. Dr. Worden's research interests include organ preservation in head and neck cancer and endocrine oncology. He is the Nancy Wigginton Oncology Research Professor of Thyroid Cancer. Avid competitive swimmer ; cyclist and runner. Dr. Worden is highly rated in 33 conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Thyroid Cancer, Throat Cancer, and Head and Neck Squamous Cell Carcinoma (HNSCC). Dr. Worden is board certified in Medical Oncology.
Rogel Cancer Center
Scott Schuetze is an Oncologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Schuetze is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Liposarcoma, Adult Soft Tissue Sarcoma, Angiosarcoma, and Myxoid Liposarcoma.
Frequently Asked Questions about Dr. Bruce Redman
How do I make an appointment with Dr. Bruce Redman?
You can book an appointment with Dr. Bruce Redman by calling their office at 734-647-8903. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Bruce Redman a top-rated expert for Renal Cell Carcinoma (RCC)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Bruce Redman is classified as an Distinguished expert for Renal Cell Carcinoma (RCC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Bruce Redman specialize in?
While Dr. Bruce Redman is a Oncology, they have specific expertise in Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, and WT1-Related Wilms Tumor Syndromes. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Bruce Redman participate in research or clinical trials?
Yes. Dr. Bruce Redman has published 30 articles and abstracts on conditions like Renal Cell Carcinoma (RCC). You can view a list of Dr. Bruce Redman's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Bruce Redman accept my insurance?
Dr. Bruce Redman accepts most major insurance plans, including Humana. We recommend calling the office directly at 734-647-8903 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Chromophobe Renal Cell CarcinomaDr. Redman isDistinguished. Learn about Chromophobe Renal Cell Carcinoma.
- Renal Cell Carcinoma (RCC)Dr. Redman isDistinguished. Learn about Renal Cell Carcinoma (RCC).
- WT1-Related Wilms Tumor SyndromesDr. Redman isDistinguished. Learn about WT1-Related Wilms Tumor Syndromes.
- Advanced
- Adult Soft Tissue SarcomaDr. Redman isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- Clear Cell SarcomaDr. Redman isAdvanced. Learn about Clear Cell Sarcoma.
- Familial Wilms Tumor 2Dr. Redman isAdvanced. Learn about Familial Wilms Tumor 2.
- MelanomaDr. Redman isAdvanced. Learn about Melanoma.
- Posterior Fossa TumorDr. Redman isAdvanced. Learn about Posterior Fossa Tumor.
- Primitive Neuroectodermal Tumor (PNET)
- Experienced
- Familial Prostate CancerDr. Redman isExperienced. Learn about Familial Prostate Cancer.
- Metastatic Brain TumorDr. Redman isExperienced. Learn about Metastatic Brain Tumor.
- Prostate CancerDr. Redman isExperienced. Learn about Prostate Cancer.